Pre-order Enquiry
Request Free Sample
Global and China IBS Treatment Market Size, Status and Forecast 2020-2026
SKU ID : QYR-16359468 | Publishing Date : 02-Sep-2020 | No. of pages : 127
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and China IBS Treatment Market Size, Status and Forecast 2020-2026
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IBS Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 IBS-D
1.2.3 IBS-C
1.2.4 IBS-M
1.3 Market by Application
1.3.1 Global IBS Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global IBS Treatment Market Perspective (2015-2026)
2.2 Global IBS Treatment Growth Trends by Regions
2.2.1 IBS Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 IBS Treatment Historic Market Share by Regions (2015-2020)
2.2.3 IBS Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IBS Treatment Players by Market Size
3.1.1 Global Top IBS Treatment Players by Revenue (2015-2020)
3.1.2 Global IBS Treatment Revenue Market Share by Players (2015-2020)
3.2 Global IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by IBS Treatment Revenue
3.4 Global IBS Treatment Market Concentration Ratio
3.4.1 Global IBS Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IBS Treatment Revenue in 2019
3.5 Key Players IBS Treatment Area Served
3.6 Key Players IBS Treatment Product Solution and Service
3.7 Date of Enter into IBS Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IBS Treatment Breakdown Data by Type (2015-2026)
4.1 Global IBS Treatment Historic Market Size by Type (2015-2020)
4.2 Global IBS Treatment Forecasted Market Size by Type (2021-2026)
5 IBS Treatment Breakdown Data by Application (2015-2026)
5.1 Global IBS Treatment Historic Market Size by Application (2015-2020)
5.2 Global IBS Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America IBS Treatment Market Size (2015-2026)
6.2 North America IBS Treatment Market Size by Type (2015-2020)
6.3 North America IBS Treatment Market Size by Application (2015-2020)
6.4 North America IBS Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe IBS Treatment Market Size (2015-2026)
7.2 Europe IBS Treatment Market Size by Type (2015-2020)
7.3 Europe IBS Treatment Market Size by Application (2015-2020)
7.4 Europe IBS Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China IBS Treatment Market Size (2015-2026)
8.2 China IBS Treatment Market Size by Type (2015-2020)
8.3 China IBS Treatment Market Size by Application (2015-2020)
8.4 China IBS Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan IBS Treatment Market Size (2015-2026)
9.2 Japan IBS Treatment Market Size by Type (2015-2020)
9.3 Japan IBS Treatment Market Size by Application (2015-2020)
9.4 Japan IBS Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia IBS Treatment Market Size (2015-2026)
10.2 Southeast Asia IBS Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia IBS Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia IBS Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Allergan Plc (Ireland)
11.1.1 Allergan Plc (Ireland) Company Details
11.1.2 Allergan Plc (Ireland) Business Overview
11.1.3 Allergan Plc (Ireland) IBS Treatment Introduction
11.1.4 Allergan Plc (Ireland) Revenue in IBS Treatment Business (2015-2020))
11.1.5 Allergan Plc (Ireland) Recent Development
11.2 Sucampo Pharmaceuticals (U.S.)
11.2.1 Sucampo Pharmaceuticals (U.S.) Company Details
11.2.2 Sucampo Pharmaceuticals (U.S.) Business Overview
11.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Introduction
11.2.4 Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020)
11.2.5 Sucampo Pharmaceuticals (U.S.) Recent Development
11.3 Ironwood Pharmaceuticals, Inc. (U.S.)
11.3.1 Ironwood Pharmaceuticals, Inc. (U.S.) Company Details
11.3.2 Ironwood Pharmaceuticals, Inc. (U.S.) Business Overview
11.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
11.3.4 Ironwood Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
11.3.5 Ironwood Pharmaceuticals, Inc. (U.S.) Recent Development
11.4 Astellas Pharma Inc. (Japan)
11.4.1 Astellas Pharma Inc. (Japan) Company Details
11.4.2 Astellas Pharma Inc. (Japan) Business Overview
11.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Introduction
11.4.4 Astellas Pharma Inc. (Japan) Revenue in IBS Treatment Business (2015-2020)
11.4.5 Astellas Pharma Inc. (Japan) Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health IBS Treatment Introduction
11.5.4 Bausch Health Revenue in IBS Treatment Business (2015-2020)
11.5.5 Bausch Health Recent Development
11.6 Abbott Laboratories (U.S.)
11.6.1 Abbott Laboratories (U.S.) Company Details
11.6.2 Abbott Laboratories (U.S.) Business Overview
11.6.3 Abbott Laboratories (U.S.) IBS Treatment Introduction
11.6.4 Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2015-2020)
11.6.5 Abbott Laboratories (U.S.) Recent Development
11.7 Synergy Pharmaceuticals, Inc. (U.S.)
11.7.1 Synergy Pharmaceuticals, Inc. (U.S.) Company Details
11.7.2 Synergy Pharmaceuticals, Inc. (U.S.) Business Overview
11.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
11.7.4 Synergy Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
11.7.5 Synergy Pharmaceuticals, Inc. (U.S.) Recent Development
11.8 Ardelyx, Inc. (U.S.)
11.8.1 Ardelyx, Inc. (U.S.) Company Details
11.8.2 Ardelyx, Inc. (U.S.) Business Overview
11.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Introduction
11.8.4 Ardelyx, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
11.8.5 Ardelyx, Inc. (U.S.) Recent Development
11.9 Nestle (Switzerland)
11.9.1 Nestle (Switzerland) Company Details
11.9.2 Nestle (Switzerland) Business Overview
11.9.3 Nestle (Switzerland) IBS Treatment Introduction
11.9.4 Nestle (Switzerland) Revenue in IBS Treatment Business (2015-2020)
11.9.5 Nestle (Switzerland) Recent Development
11.10 Sebela Pharmaceuticals (Ireland)
11.10.1 Sebela Pharmaceuticals (Ireland) Company Details
11.10.2 Sebela Pharmaceuticals (Ireland) Business Overview
11.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Introduction
11.10.4 Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2015-2020)
11.10.5 Sebela Pharmaceuticals (Ireland) Recent Development
11.11 Probi (Sweden)
10.11.1 Probi (Sweden) Company Details
10.11.2 Probi (Sweden) Business Overview
10.11.3 Probi (Sweden) IBS Treatment Introduction
10.11.4 Probi (Sweden) Revenue in IBS Treatment Business (2015-2020)
10.11.5 Probi (Sweden) Recent Development
11.12 Alfasigma USA, Inc. (Italy)
10.12.1 Alfasigma USA, Inc. (Italy) Company Details
10.12.2 Alfasigma USA, Inc. (Italy) Business Overview
10.12.3 Alfasigma USA, Inc. (Italy) IBS Treatment Introduction
10.12.4 Alfasigma USA, Inc. (Italy) Revenue in IBS Treatment Business (2015-2020)
10.12.5 Alfasigma USA, Inc. (Italy) Recent Development
11.13 RedHill Biopharma Ltd. (Israel)
10.13.1 RedHill Biopharma Ltd. (Israel) Company Details
10.13.2 RedHill Biopharma Ltd. (Israel) Business Overview
10.13.3 RedHill Biopharma Ltd. (Israel) IBS Treatment Introduction
10.13.4 RedHill Biopharma Ltd. (Israel) Revenue in IBS Treatment Business (2015-2020)
10.13.5 RedHill Biopharma Ltd. (Israel) Recent Development
11.14 AstraZeneca (U.K)
10.14.1 AstraZeneca (U.K) Company Details
10.14.2 AstraZeneca (U.K) Business Overview
10.14.3 AstraZeneca (U.K) IBS Treatment Introduction
10.14.4 AstraZeneca (U.K) Revenue in IBS Treatment Business (2015-2020)
10.14.5 AstraZeneca (U.K) Recent Development
11.15 Ipsen (France)
10.15.1 Ipsen (France) Company Details
10.15.2 Ipsen (France) Business Overview
10.15.3 Ipsen (France) IBS Treatment Introduction
10.15.4 Ipsen (France) Revenue in IBS Treatment Business (2015-2020)
10.15.5 Ipsen (France) Recent Development
11.16 Novartis AG (Switzerland)
10.16.1 Novartis AG (Switzerland) Company Details
10.16.2 Novartis AG (Switzerland) Business Overview
10.16.3 Novartis AG (Switzerland) IBS Treatment Introduction
10.16.4 Novartis AG (Switzerland) Revenue in IBS Treatment Business (2015-2020)
10.16.5 Novartis AG (Switzerland) Recent Development
11.17 Takeda Pharmaceutical Company Ltd (Japan)
10.17.1 Takeda Pharmaceutical Company Ltd (Japan) Company Details
10.17.2 Takeda Pharmaceutical Company Ltd (Japan) Business Overview
10.17.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Introduction
10.17.4 Takeda Pharmaceutical Company Ltd (Japan) Revenue in IBS Treatment Business (2015-2020)
10.17.5 Takeda Pharmaceutical Company Ltd (Japan) Recent Development
11.18 Synthetic Biologics, Inc. (U.S.)
10.18.1 Synthetic Biologics, Inc. (U.S.) Company Details
10.18.2 Synthetic Biologics, Inc. (U.S.) Business Overview
10.18.3 Synthetic Biologics, Inc. (U.S.) IBS Treatment Introduction
10.18.4 Synthetic Biologics, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.18.5 Synthetic Biologics, Inc. (U.S.) Recent Development
11.19 Protagonist Therapeutics Inc. (U.S.)
10.19.1 Protagonist Therapeutics Inc. (U.S.) Company Details
10.19.2 Protagonist Therapeutics Inc. (U.S.) Business Overview
10.19.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Introduction
10.19.4 Protagonist Therapeutics Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.19.5 Protagonist Therapeutics Inc. (U.S.) Recent Development
11.20 Pfizer Inc (U.S.)
10.20.1 Pfizer Inc (U.S.) Company Details
10.20.2 Pfizer Inc (U.S.) Business Overview
10.20.3 Pfizer Inc (U.S.) IBS Treatment Introduction
10.20.4 Pfizer Inc (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.20.5 Pfizer Inc (U.S.) Recent Development
11.21 Lexicon Pharmaceuticals, Inc. (U.S.)
10.21.1 Lexicon Pharmaceuticals, Inc. (U.S.) Company Details
10.21.2 Lexicon Pharmaceuticals, Inc. (U.S.) Business Overview
10.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
10.21.4 Lexicon Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.21.5 Lexicon Pharmaceuticals, Inc. (U.S.) Recent Development
11.22 Innovate Biopharmaceuticals (U.S.)
10.22.1 Innovate Biopharmaceuticals (U.S.) Company Details
10.22.2 Innovate Biopharmaceuticals (U.S.) Business Overview
10.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Introduction
10.22.4 Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020)
10.22.5 Innovate Biopharmaceuticals (U.S.) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and China IBS Treatment Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Global IBS Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of IBS-D
Table 4. Key Players of IBS-C
Table 5. Key Players of IBS-M
Table 6. Global IBS Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global IBS Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global IBS Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global IBS Treatment Market Share by Regions (2015-2020)
Table 10. Global IBS Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global IBS Treatment Market Share by Regions (2021-2026)
Table 12. IBS Treatment Market Market Trends
Table 13. IBS Treatment Market Drivers
Table 14. IBS Treatment Market Challenges
Table 15. IBS Treatment Market Restraints
Table 16. Global IBS Treatment Revenue by Players (2015-2020) (US$ Million)
Table 17. Global IBS Treatment Market Share by Players (2015-2020)
Table 18. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS Treatment as of 2019)
Table 19. Global IBS Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players IBS Treatment Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IBS Treatment Market Size by Type (2015-2020) (US$ Million)
Table 24. Global IBS Treatment Market Size Share by Type (2015-2020)
Table 25. Global IBS Treatment Revenue Market Share by Type (2021-2026)
Table 26. Global IBS Treatment Market Size Share by Application (2015-2020)
Table 27. Global IBS Treatment Market Size by Application (2015-2020) (US$ Million)
Table 28. Global IBS Treatment Market Size Share by Application (2021-2026)
Table 29. North America IBS Treatment Market Size by Type (2015-2020) (US$ Million)
Table 30. North America IBS Treatment Market Share by Type (2015-2020)
Table 31. North America IBS Treatment Market Size by Application (2015-2020) (US$ Million)
Table 32. North America IBS Treatment Market Share by Application (2015-2020)
Table 33. North America IBS Treatment Market Size by Country (US$ Million) (2015-2020)
Table 34. North America IBS Treatment Market Share by Country (2015-2020)
Table 35. Europe IBS Treatment Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe IBS Treatment Market Share by Type (2015-2020)
Table 37. Europe IBS Treatment Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe IBS Treatment Market Share by Application (2015-2020)
Table 39. Europe IBS Treatment Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe IBS Treatment Market Share by Country (2015-2020)
Table 41. China IBS Treatment Market Size by Type (2015-2020) (US$ Million)
Table 42. China IBS Treatment Market Share by Type (2015-2020)
Table 43. China IBS Treatment Market Size by Application (2015-2020) (US$ Million)
Table 44. China IBS Treatment Market Share by Application (2015-2020)
Table 45. China IBS Treatment Market Size by Region (US$ Million) (2015-2020)
Table 46. China IBS Treatment Market Share by Region (2015-2020)
Table 47. Japan IBS Treatment Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan IBS Treatment Market Share by Type (2015-2020)
Table 49. Japan IBS Treatment Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan IBS Treatment Market Share by Application (2015-2020)
Table 51. Japan IBS Treatment Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan IBS Treatment Market Share by Country (2015-2020)
Table 53. Southeast Asia IBS Treatment Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia IBS Treatment Market Share by Type (2015-2020)
Table 55. Southeast Asia IBS Treatment Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia IBS Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia IBS Treatment Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia IBS Treatment Market Share by Country (2015-2020)
Table 59. Allergan Plc (Ireland) Company Details
Table 60. Allergan Plc (Ireland) Business Overview
Table 61. Allergan Plc (Ireland) Product
Table 62. Allergan Plc (Ireland) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 63. Allergan Plc (Ireland) Recent Development
Table 64. Sucampo Pharmaceuticals (U.S.) Company Details
Table 65. Sucampo Pharmaceuticals (U.S.) Business Overview
Table 66. Sucampo Pharmaceuticals (U.S.) Product
Table 67. Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 68. Sucampo Pharmaceuticals (U.S.) Recent Development
Table 69. Ironwood Pharmaceuticals, Inc. (U.S.) Company Details
Table 70. Ironwood Pharmaceuticals, Inc. (U.S.) Business Overview
Table 71. Ironwood Pharmaceuticals, Inc. (U.S.) Product
Table 72. Ironwood Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 73. Ironwood Pharmaceuticals, Inc. (U.S.) Recent Development
Table 74. Astellas Pharma Inc. (Japan) Company Details
Table 75. Astellas Pharma Inc. (Japan) Business Overview
Table 76. Astellas Pharma Inc. (Japan) Product
Table 77. Astellas Pharma Inc. (Japan) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 78. Astellas Pharma Inc. (Japan) Recent Development
Table 79. Bausch Health Company Details
Table 80. Bausch Health Business Overview
Table 81. Bausch Health Product
Table 82. Bausch Health Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 83. Bausch Health Recent Development
Table 84. Abbott Laboratories (U.S.) Company Details
Table 85. Abbott Laboratories (U.S.) Business Overview
Table 86. Abbott Laboratories (U.S.) Product
Table 87. Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 88. Abbott Laboratories (U.S.) Recent Development
Table 89. Synergy Pharmaceuticals, Inc. (U.S.) Company Details
Table 90. Synergy Pharmaceuticals, Inc. (U.S.) Business Overview
Table 91. Synergy Pharmaceuticals, Inc. (U.S.) Product
Table 92. Synergy Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 93. Synergy Pharmaceuticals, Inc. (U.S.) Recent Development
Table 94. Ardelyx, Inc. (U.S.) Business Overview
Table 95. Ardelyx, Inc. (U.S.) Product
Table 96. Ardelyx, Inc. (U.S.) Company Details
Table 97. Ardelyx, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 98. Ardelyx, Inc. (U.S.) Recent Development
Table 99. Nestle (Switzerland) Company Details
Table 100. Nestle (Switzerland) Business Overview
Table 101. Nestle (Switzerland) Product
Table 102. Nestle (Switzerland) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 103. Nestle (Switzerland) Recent Development
Table 104. Sebela Pharmaceuticals (Ireland) Company Details
Table 105. Sebela Pharmaceuticals (Ireland) Business Overview
Table 106. Sebela Pharmaceuticals (Ireland) Product
Table 107. Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 108. Sebela Pharmaceuticals (Ireland) Recent Development
Table 109. Probi (Sweden) Company Details
Table 110. Probi (Sweden) Business Overview
Table 111. Probi (Sweden) Product
Table 112. Probi (Sweden) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 113. Probi (Sweden) Recent Development
Table 114. Alfasigma USA, Inc. (Italy) Company Details
Table 115. Alfasigma USA, Inc. (Italy) Business Overview
Table 116. Alfasigma USA, Inc. (Italy) Product
Table 117. Alfasigma USA, Inc. (Italy) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 118. Alfasigma USA, Inc. (Italy) Recent Development
Table 119. RedHill Biopharma Ltd. (Israel) Company Details
Table 120. RedHill Biopharma Ltd. (Israel) Business Overview
Table 121. RedHill Biopharma Ltd. (Israel) Product
Table 122. RedHill Biopharma Ltd. (Israel) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 123. RedHill Biopharma Ltd. (Israel) Recent Development
Table 124. AstraZeneca (U.K) Company Details
Table 125. AstraZeneca (U.K) Business Overview
Table 126. AstraZeneca (U.K) Product
Table 127. AstraZeneca (U.K) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 128. AstraZeneca (U.K) Recent Development
Table 129. Ipsen (France) Company Details
Table 130. Ipsen (France) Business Overview
Table 131. Ipsen (France) Product
Table 132. Ipsen (France) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 133. Ipsen (France) Recent Development
Table 134. Novartis AG (Switzerland) Company Details
Table 135. Novartis AG (Switzerland) Business Overview
Table 136. Novartis AG (Switzerland) Product
Table 137. Novartis AG (Switzerland) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 138. Novartis AG (Switzerland) Recent Development
Table 139. Takeda Pharmaceutical Company Ltd (Japan) Company Details
Table 140. Takeda Pharmaceutical Company Ltd (Japan) Business Overview
Table 141. Takeda Pharmaceutical Company Ltd (Japan) Product
Table 142. Takeda Pharmaceutical Company Ltd (Japan) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 143. Takeda Pharmaceutical Company Ltd (Japan) Recent Development
Table 144. Synthetic Biologics, Inc. (U.S.) Company Details
Table 145. Synthetic Biologics, Inc. (U.S.) Business Overview
Table 146. Synthetic Biologics, Inc. (U.S.) Product
Table 147. Synthetic Biologics, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 148. Synthetic Biologics, Inc. (U.S.) Recent Development
Table 149. Protagonist Therapeutics Inc. (U.S.) Company Details
Table 150. Protagonist Therapeutics Inc. (U.S.) Business Overview
Table 151. Protagonist Therapeutics Inc. (U.S.) Product
Table 152. Protagonist Therapeutics Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 153. Protagonist Therapeutics Inc. (U.S.) Recent Development
Table 154. Pfizer Inc (U.S.) Company Details
Table 155. Pfizer Inc (U.S.) Business Overview
Table 156. Pfizer Inc (U.S.) Product
Table 157. Pfizer Inc (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 158. Pfizer Inc (U.S.) Recent Development
Table 159. Lexicon Pharmaceuticals, Inc. (U.S.) Company Details
Table 160. Lexicon Pharmaceuticals, Inc. (U.S.) Business Overview
Table 161. Lexicon Pharmaceuticals, Inc. (U.S.) Product
Table 162. Lexicon Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 163. Lexicon Pharmaceuticals, Inc. (U.S.) Recent Development
Table 164. Innovate Biopharmaceuticals (U.S.) Company Details
Table 165. Innovate Biopharmaceuticals (U.S.) Business Overview
Table 166. Innovate Biopharmaceuticals (U.S.) Product
Table 167. Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020) (US$ Million)
Table 168. Innovate Biopharmaceuticals (U.S.) Recent Development
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IBS Treatment Market Share by Type: 2020 VS 2026
Figure 2. IBS-D Features
Figure 3. IBS-C Features
Figure 4. IBS-M Features
Figure 5. Global IBS Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Laboratories Case Studies
Figure 9. IBS Treatment Report Years Considered
Figure 10. Global IBS Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global IBS Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global IBS Treatment Market Share by Regions (2021-2026)
Figure 13. Global IBS Treatment Market Share by Players in 2019
Figure 14. Global Top IBS Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IBS Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by IBS Treatment Revenue in 2019
Figure 16. North America IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa IBS Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Allergan Plc (Ireland) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 44. Sucampo Pharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 45. Ironwood Pharmaceuticals, Inc. (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 46. Astellas Pharma Inc. (Japan) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 47. Bausch Health Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 48. Abbott Laboratories (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 49. Synergy Pharmaceuticals, Inc. (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 50. Ardelyx, Inc. (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 51. Nestle (Switzerland) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 52. Sebela Pharmaceuticals (Ireland) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 53. Probi (Sweden) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 54. Alfasigma USA, Inc. (Italy) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 55. RedHill Biopharma Ltd. (Israel) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 56. AstraZeneca (U.K) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 57. Ipsen (France) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 58. Novartis AG (Switzerland) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 59. Takeda Pharmaceutical Company Ltd (Japan) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 60. Synthetic Biologics, Inc. (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 61. Protagonist Therapeutics Inc. (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 62. Pfizer Inc (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 63. Lexicon Pharmaceuticals, Inc. (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 64. Innovate Biopharmaceuticals (U.S.) Revenue Growth Rate in IBS Treatment Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global and China IBS Treatment Market Size, Status and Forecast 2020-2026
Allergan Plc (Ireland)Sucampo Pharmaceuticals (U.S.)
Ironwood Pharmaceuticals, Inc. (U.S.)
Astellas Pharma Inc. (Japan)
Bausch Health
Abbott Laboratories (U.S.)
Synergy Pharmaceuticals, Inc. (U.S.)
Ardelyx, Inc. (U.S.)
Nestle (Switzerland)
Sebela Pharmaceuticals (Ireland)
Probi (Sweden)
Alfasigma USA, Inc. (Italy)
RedHill Biopharma Ltd. (Israel)
AstraZeneca (U.K)
Ipsen (France)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Ltd (Japan)
Synthetic Biologics, Inc. (U.S.)
Protagonist Therapeutics Inc. (U.S.)
Pfizer Inc (U.S.)
Lexicon Pharmaceuticals, Inc. (U.S.)
Innovate Biopharmaceuticals (U.S.)
